Subclonal neoantigens present a key roadblock in MMRd tumor immunotherapy success

The EC granted approval for Bristol Myers Squibb’s Camzyosb based on the positive safety and efficacy data from two Phase III trials. Credit: Bristol-Myers Squibb

Social media use among adolescents and young adults was associated with a higher likelihood of smoking and vaping, a national longitudinal study from the U.K.